𝔖 Bobbio Scriptorium

✦ LIBER ✦

Is the vasopressin release the crucial factor in the pathogenesis of hypervolemic hyponatremia in patients with cirrhosis and ascites?

✍ Scribed by Piano, S.; Gola, E.; Sticca, A.; Morando, F.; Cavallin, M.; Rosi, S.; Stanco, M.; Romano, A.; Fasolato, S.; Gatta, A.; Angeli, P.

Book ID: 122894044
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 58 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2014.01.134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P35 IS THE VASOPRESSIN RELEASE THE CRUCI

P35 IS THE VASOPRESSIN RELEASE THE CRUCIAL FACTOR IN THE PATHOGENESIS OF HYPERVOLEMIC HYPONATREMIA IN PATIENTS WITH CIRRHOSIS AND ASCITES?

✍ Piano, S.; Gola, E.; Sticca, A.; Morando, F.; Cavallin, M.; Rosi, S.; Stanco, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

648 HYPONATREMIA IS A MAJOR FACTOR OF TH

648 HYPONATREMIA IS A MAJOR FACTOR OF THE IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CIRRHOSIS AND ASCITES

✍ E. Solá; M. Guevara; E. Rodriguez; R. Barreto; M. Pavesi; V. Arroyo; E. Smadja-L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Pathogenesis of solute-free water retent

Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: Is vasopressin (ADH) the only agent to blame?

✍ Sansoè, G.; Aragno, M.; Mastrocola, R.; Parola, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Renin, aldosterone and arginine vasopres

Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: the influence of ascites retransfusion

✍ P. BURMEISTER; J. SCHÖLMERICH; W. DIENER; W. GEROK 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

Torasemide in the treatment of patients

Torasemide in the treatment of patients with cirrhosis and ascites

✍ Paolo Gentilini; Giacomo Laffi; Giorgio La Villa; Vinicio Carloni; Marco Foschi; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 493 KB

Torasemide in the treatment of patients

Torasemide in the treatment of patients with cirrhosis and ascites

✍ Paolo Gentilini; Giacomo Laffi; Giorgio La Villa; Vinicio Carloni; Marco Foschi; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 493 KB

The effects of torasemide (20 mg/day) and furosemide (50 mg/day), each given over 4 days, were compared in a randomized and crossover study carried out in seven patients with cirrhosis and tense ascites. Patients also received a low-sodium (40 mmol/day) diet and the aldosterone antagonist, potassium